CTX213

Serial Number 98955696
681

Registration Progress

Application Filed
Jan 13, 2025
Under Examination
Approved for Publication
Published for Opposition
Jul 29, 2025
Registered

Trademark Image

CTX213

Basic Information

Serial Number
98955696
Filing Date
January 13, 2025
Published for Opposition
July 29, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
681
Status Date
Jul 16, 2025
Application
Pending
Classes
005 042

Rights Holder

CRISPR Therapeutics AG

25
Address
Baarerstrasse 14
ZUG V8 6300
CH

Ownership History

CRISPR Therapeutics AG

Original Applicant
25
ZUG V8 CH

Legal Representation

Attorney
Tiffany D. Gehrke

Application History

5 events
Date Code Type Description Documents
Jun 24, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 21, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 10, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 13, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 13, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Cells for medical or clinical use in the field of stem cell therapy for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes; pharmaceutical and biopharmaceutical agents for the treatment of diabetes
Class 042
gene editing, namely, pharmaceutical research and development in the field of stem cell therapy for the treatment of diabetes; Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of stem cell therapy for the treatment of diabetes

Additional Information

Pseudo Mark
CTX TWO ONE THREE
Pseudo Mark
CTX TWO HUNDRED THIRTEEN

Classification

International Classes
005 042